Compounds > 1,2-distearoylphosphatidylethanolamine
Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and Prostatic Neoplasms

1,2-distearoylphosphatidylethanolamine has been researched along with Prostatic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Dai, Z; Gao, C; Liang, X; Mao, Y; Qiu, C; Qu, E; Wang, X; Yin, T; You, Y; Zheng, R1
Cui, J; Li, C; Li, Y; Wang, C; Wei, N; Xiu, X; Zhang, L1
Evjen, TJ; Fossheim, SL; Hagtvet, E; Nilssen, EA; Olsen, DR1

Other Studies

3 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Prostatic Neoplasms

ArticleYear
Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
    Theranostics, 2018, Volume: 8, Issue:6

    Topics: Animals; Cell Line, Tumor; Cholesterol; Combined Modality Therapy; Contrast Media; Humans; Male; Mice; Mice, Nude; Microbubbles; Nanoparticles; Phosphatidylcholines; Phosphatidylethanolamines; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Surgery, Computer-Assisted; Theranostic Nanomedicine; Ultrasonography; Xenograft Model Antitumor Assays

2018
Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
    Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:7

    Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Female; Injections, Intravenous; Kinetics; Liposomes; Male; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Models, Chemical; Phosphatidylethanolamines; Polyethylene Glycols; Prostatic Neoplasms; Solubility; Technology, Pharmaceutical; Tumor Burden; Vincristine

2011
Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice.
    Journal of drug targeting, 2011, Volume: 19, Issue:8

    Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Carriers; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phonophoresis; Phosphatidylethanolamines; Prostatic Neoplasms; Tissue Distribution; Xenograft Model Antitumor Assays

2011